Effect of Tocilizumab on Mortality in Patients with SARS-CoV-2 Pneumonia Caused by Delta or Omicron Variants: A Propensity-Matched Analysis in Nimes University Hospital, France

• Main Authors: Paul Laffont-Lozes (Author), Didier Laureillard (Author), Paul Loubet (Author), Robin Stephan (Author), Myriam Chiaruzzi (Author), Edouard Clemmer (Author), Aurelie Martin (Author), Claire Roger (Author), Laurent Muller (Author), Pierre-Géraud Claret (Author), Radjiv Goulabchand (Author), Clarisse Roux (Author), Jean-Philippe Lavigne (Author), Albert Sotto (Author), Romaric Larcher (Author)
• Format: Book
• Published: MDPI AG, 2023-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

We aimed to assess the factors associated with mortality in patients treated with tocilizumab for a SARS-CoV-2 pneumonia due to the delta or omicron variants of concern (VOC) and detect an effect of tocilizumab on mortality. We conducted a prospective cohort study in a tertiary hospital from 1 Augus...